May 24, 2023
Strategic Multilayer Assessment (SMA) General Speaker Session
“At times, biotechnology appears to blend science fiction and reality. The potential warfighting applications of biotechnology and the size of the bioeconomy has made biotechnology a focus point of the US-China rivalry. Dr. Biberman described the different steps and viewpoints of both nations relating to biotechnology and bioengineered weaponry. Since 2006, Chinese military officials have commented on the potential benefits of integrating biotechnology into the armed forces. A current perception is that China is one step ahead of the US. China focused on military-civil fusion during the 1990s and developed a five-year bioeconomic plan for 2021-2025. However, Dr. Biberman clarified that the US retains some dominance. The Biden Administration has acted to ensure the US remains ahead of China, including signing an executive order to advance biotechnology and biomanufacturing innovation. The order is designed to grow the US bioeconomy while also ensuring that this growth is achieved sustainably, safely, and ethically.”
Back to Library